Cited by 8Liver physiology and pathologyOrgan Transplantation Techniques and OutcomesTissue Engineering and Regenerative Medicine

EGFR-mediated crosstalk between vascular endothelial cells and hepatocytes promotes Piezo1-dependent liver regeneration

Open access
Hu, Yuelei, Du, Guifang, Li, Chao, Wang, Rui, Liu, Juan, Wang, Yunfang, Dong, Jiahong·2025·Genes & Diseases

Abstract

Hepatocyte proliferation is essential for recovering liver function after injury. In liver surgery, the mechanical stimulation induced by hemodynamic changes triggers vascular endothelial cells (VECs) to secrete large amounts of cytokines that enhance hepatocyte proliferation and play a pivotal role in liver regeneration (LR). Piezo1, a critical mechanosensory ion channel, can detect and convert mechanical forces into chemical signals, importing external stimuli into cells and triggering downstream biological effects. However, the precise role of Piezo1 in VECs, especially in terms of mediating LR, remains unclear. Here, we report on a potential mechanism by which early changes in hepatic portal hemodynamics activate Piezo1 in VECs to promote hepatocyte proliferation during the process of LR induced by portal vein ligation in rats. In this LR model, hepatocyte proliferation is mainly distributed in zone 1 and zone 2 of liver lobules at 24-48 h after surgery, while only a small number of Ki67-positive hepatocytes were observed in zone 3. Activation of Piezo1 promotes increased secretion of epiregulin and amphiregulin from VECs via the PKC/ERK1/2 axis, further activating epidermal growth factor receptor (EGFR) and ERK1/2 signals in hepatocytes and promoting proliferation. In the liver lobules, the expression of EGFR in hepatocytes of zone 1 and zone 2 is significantly higher than that in zone 3. The EGFR inhibitor gefitinib inhibits LR by suppressing the proliferation of hepatocytes in the middle zone. These data provide a theoretical basis for the regulation of LR through chemical signals mediated by mechanical stimulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.gendis.2024.101321

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The direction of regenerative processes following liver tissue damage is determined by changes in portal pressure and flow.

    “Our long-term studies, supported by literature data, indicate that the direction of regenerative processes following liver tissue damage is determined by changes in portal pressure and flow—which act as mechanical and physiological determinants[4,9,11,12].”

    From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [4]

    The Introduction says hemodynamic changes help initiate and regulate liver regeneration, and the Results report regeneration on the non-ligated side of a rat portal-vein-ligation model. The paper supports a role for portal flow and mechanical forces, but it does not establish that changes in both portal pressure and flow determine the direction of regenerative processes after liver tissue damage generally. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • After resection of more than 50% of the liver, the blood supply previously directed to the entire liver is redistributed to the remaining liver tissue, resulting in increased pressure and flow that triggers proliferative (hyperplastic) regeneration.

    “In contrast, after resection more than 50% of the liver, the blood supply previously directed to the entire liver, is redistributed to the remaining liver tissue, resulting in increased pressure and flow. This triggers a cascade of cellular proliferation, leading to proliferative (hyperplastic) regeneration[4].”

    From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [4]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • AREG and EREG activate EGFR signaling in hepatocytes, driving their proliferation, especially in liver zones 1 and 2.

    “These ligands activate epidermal growth factor receptor (EGFR) signaling in hepatocytes driving their proliferation, especially in liver zones 1 and 2[4,20].”

    From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [4]

    The Results section reports that AREG and EREG activate EGFR and promote proliferation in LO2 hepatocytes. It also reports higher EGFR expression in zones 1 and 2 than in zone 3, but does not show that AREG- and EREG-driven proliferation occurs especially in those zones; the proposed link between ligand secretion and regional proliferation is presented as a suggestion. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Piezo1 upregulates the expression and secretion of amphiregulin (AREG) and epiregulin (EREG) via the PKC/ERK1/2 signaling axis.

    “Piezo1, in turn, upregulates the expression and secretion of amphiregulin (AREG) and epiregulin (EREG) via the protein kinase C/extracellular signal-regulated kinases 1 and 2 (PKC/ERK1/2) signaling axis[4].”

    From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [4]

    In the Results section on PKC and ERK1/2 regulation in vascular endothelial cells, Yoda1-induced Piezo1 activation increased AREG and EREG expression, and PKC and ERK1/2 inhibitors blocked that increase. The same section reports that Piezo1 knockdown inhibited AREG and EREG secretion. It does not establish that secretion itself is mediated through the PKC/ERK1/2 axis. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 29 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Hu, Y., Du, G., Li, C., Wang, R., Liu, J., Wang, Y., & Dong, J.
Affiliations
  • Jilin University (CN)
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Tsinghua University (CN)
Corresponding author
  • Liu, Juan
  • Wang, Yunfang
  • Dong, Jiahong
Venue
Genes & Diseases
Publisher
Elsevier BV
Published
2025-05
Volume
12
Issue
3
Pages
101321
ISSN
2352-3042 (ISSN-L)
OpenAlex
W4396732101
Cited by
7
References
29
Citations by year
2026: 4 · 2025: 3
FWCI
1.83
Type
journal article
Language
en
Open access
Locations
  • Genes & Diseases (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Key Research and Development Program of China Stem Cell and Translational Research
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
liver regeneration, Piezo1, vascular endothelial cells, hepatocyte proliferation, EGFR signaling, epiregulin, amphiregulin, portal vein ligation, hemodynamic changes, mechanosensing, gefitinib

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review